Revvity Inc (RVTY) Actualités

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Revvity, Inc. (NYSE: RVTY), today announced an expansion of its work with Genomics England that leverages both organizations' expertise and...

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Revvity, Inc. (NYSE: RVTY), will present at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024, at 8:20 a.m. ET in...

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

Revvity, Inc. (NYSE: RVTY), today announced it will host an Investor Day on Thursday, November 21, 2024 at 9:00 a.m. PT which will feature...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Revvity Announces Financial Results for the Third Quarter of 2024

Revenue of $684 million; 2% reported growth; 2% organic growth GAAP EPS of $0.77; Adjusted EPS from continuing operations of $1.28 Raises full...

Revvity Board Declares Quarterly Dividend

The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This...

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories

Enables transcription of handwritten test request forms to digitized format Utilizes innovative AI for higher accuracy and efficiency Data is...

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report

Revvity, Inc. (NYSE: RVTY) today unveils its annual Impact Report, a declaration of the Company’s sustainability, social and governance strategy...